Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heart-Lung Machine: Impact of the Priming Solution on the Body's Acid-Base Balance, Electrolyte Composition and Clinical Outcome (PRIMEII)

NCT07267546 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT07267546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07267546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heart-Lung Machine: Impact of the Priming Solution on the Body's Acid-Base Balance, Electrolyte Composition and Clinical Outcome (PRIMEII)
Lead sponsor
Region Skane
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2025
Completion date
November 1, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acid base imbalance, cardiopulmonary bypass, crystalloid solutions, electrolyte changes, osmolality disturbance